All lobbying filings

ALPEX INTERNATIONAL, LLC

ALPEX INTERNATIONAL, LLC filed a Q1 report for ONWARD MEDICAL, INC. on April 16, 2026, reporting $10,000 in lobbying income.

Lobbying for ONWARD MEDICAL, INC. · Medical technology

All filings by ALPEX INTERNATIONAL, LLC · Everything ONWARD MEDICAL, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 16, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Veterans

Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes

Budget/Appropriations

Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military and civilian personnel; Issues related to the implementation of Public Law No: 118-50, Making emergency supplemental appropriations for the fiscal year ending September 30, 2024, and for other purposes

Tariff (miscellaneous tariff bills)

Issues related to the "Nairobi Protocol" tariff treatment that grants duty-free importation status to educational, scientific, and cultural materials - specifically expanding coverage to include articles for handicapped persons - 1121 of the Omnibus Trade and Competitiveness Act of 1988 (Pub. L. 100-418, 102 Stat. 1107) and Presidential Proclamation 5978 (54 FR 21187).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.